Evidence map›Paper›PMID 42186678›Full record

ReviewInternational endodontic journal2026

Redefining the Evolution of Pulpal Pathology: Inflammasomes as Central Integrative Hubs and Biological Switches Governing the Transition From Reversible to Irreversible Pulpal Inflammation Beyond Symptom-Based Classification.

Néstor Ríos-Osorio, James L Gutmann, Tatiana M Botero, Nessrin Taha, Rafael Fernández-Grisales, Mario Guerrero-Torres, Emmanuel J N L Silva, Javier Caviedes-Bucheli

Abstract readReview
In one paragraph

Review in International endodontic journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Néstor Ríos-OsorioDepartment of Endodontics, School of Dentistry, CES University, Medellín, Colombia.ORCID https://orcid.org/0000-0002-6675-6789
James L GutmannDepartment of Endodontics, College of Dentistry, Texas A&M University, Dallas, Texas, USA.ORCID https://orcid.org/0000-0003-3081-2635
Tatiana M BoteroDepartment of Cariology, Restorative Sciences and Endodontics, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-8820-2306
Nessrin TahaDepartment of Conservative Dentistry, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0003-3233-8850
Rafael Fernández-GrisalesDepartment of Endodontics, School of Dentistry, CES University, Medellín, Colombia.ORCID https://orcid.org/0000-0002-1431-8373
Mario Guerrero-TorresFaculty of Dentistry, Universidad Santo Tomas, Bucaramanga, Colombia.ORCID https://orcid.org/0000-0003-3660-4925
Emmanuel J N L SilvaPost-Graduate Program in Translational Biomedicine (BIOTRANS), Grande Rio University (UNIGRANRIO), Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-6445-8243
Javier Caviedes-BucheliCentro de Investigaciones Odontológicas, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID https://orcid.org/0000-0003-0407-9847

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe transition from reversible to irreversible pulpitis remains inadequately defined at the molecular level. Current classifications rely largely on clinical symptoms rather than objective biological determinants, limiting diagnostic precision and therapeutic decision-making.

objectivesTo integrate current experimental and translational evidence positioning inflammasomes as central molecular decision-making platforms in pulpal inflammation, and to propose a biologically grounded model in which inflammasome activation and supramolecular assembly define the threshold separating adaptive, reversible inflammation from irreversible pulpal damage, with direct clinical implications.

methodsA structured narrative review was conducted following a comprehensive literature search of PubMed/MEDLINE, Scopus, and Web of Science from inception to December 2025. Evidence derived from in vitro systems, in vivo animal models, and analyses of human inflamed pulpal tissues was synthesised to characterise inflammasome sensors, adaptor and effector components, regulatory checkpoints, downstream inflammatory outputs, and their relevance to pulpal disease progression.

resultsDental pulp cells express functional inflammasome sensors, including NLRP3, AIM2, and NLRP6, which respond to inflammatory, metabolic, and damage-associated signals. Inflammasome activation follows a stepwise process of transcriptional priming and threshold-dependent assembly. While NF-κB- and type I interferon-mediated priming is adaptive and potentially reversible, ASC speck formation represents a molecular commitment point leading to caspase-1 activation, gasdermin D cleavage, IL-1β/IL-18 maturation, and pyroptotic cell death. Mitochondrial dysfunction, cytosolic mtDNA release, sustained ion fluxes, P2X7 signalling, and loss of endogenous inhibitory regulators further amplify inflammasome activity, promoting self-sustaining inflammatory circuits and progressive tissue breakdown.

conclusionsPulpal inflammation should be understood not as a linear increase in microbial burden, but as a biological transition driven by inflammasome checkpoint failure. Irreversible ASC speck formation functions as a commitment switch that sustains caspase-1 activation, gasdermin D-mediated pyroptosis, and self-amplifying IL-1β/IL-18 signalling. Within the confined pulp environment, this feed-forward inflammatory circuitry promotes neurovascular dysregulation and severe pain, ultimately becoming uncoupled from the initiating insult and incompatible with tissue recovery. Recognising Inflammasome activation (ASC speck formation) as a point of no return may refine diagnostic paradigms and help redefine the biological limits of vital pulp therapy.

Indexed as

Dental PulpInflammasomesPulpitisAnimalsHumansInflammasomesendodontic diagnosisimmune responseinflammasomeinflammationpulpitispyroptosis

Identifiers

PMID42186678
PMCPMC13569147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.